Back
Corporate News
Bal Pharma Limited’s board will convene August 12 to review quarterly financial results
05-Aug-2026, 05:52
Bal Pharma Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
Bal Pharma Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
